Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Cascade Cancer Center at Evergreen Hospital Medical Center
mi
from
Kirkland, WA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Cascade Cancer Center at Evergreen Hospital Medical Center
mi
from
Kirkland, WA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Olympic Medical Center
mi
from
Port Angeles, WA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Olympic Medical Center
mi
from
Port Angeles, WA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Southlake Clinic
mi
from
Renton, WA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Southlake Clinic
mi
from
Renton, WA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - Virginia Mason Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Southwest Washington Medical Center Cancer Center
mi
from
Vancouver, WA
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Southwest Washington Medical Center Cancer Center
mi
from
Vancouver, WA
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Central Wisconsin Cancer Program at Agnesian HealthCare
mi
from
Fond du Lac, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Central Wisconsin Cancer Program at Agnesian HealthCare
mi
from
Fond du Lac, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Franciscan Skemp Healthcare - La Crosse Campus
mi
from
La Crosse, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Bay Area Cancer Care Center at Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Welch Cancer Center at Sheridan Memorial Hospital
mi
from
Sheridan, WY
Click here to add this to my saved trials
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
A Retrospective Analysis of Fetal Outcome Compared to Massively Parallel Sequencing Test Results Obtained From Multiple Gestation Pregnancies at Increased Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated:  9/15/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
A Retrospective Analysis of Fetal Outcome Compared to Massively Parallel Sequencing Test Results Obtained From Multiple Gestation Pregnancies at Increased Risk for Fetal Chromosomal Aneuploidy
Status: Enrolling
Updated: 9/15/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
Status: Enrolling
Updated:  9/21/2015
Massachusetts Institute of Technology
mi
from
Cambridge, MA
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease
Status: Enrolling
Updated: 9/21/2015
Massachusetts Institute of Technology
mi
from
Cambridge, MA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Mesa, AZ
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Carlsbad, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Castro Valley, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Laguna Hills, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
San Francisco, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Sylmar, CA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Hialeah, FL
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Miami, FL
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
South Miami, FL
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Chicago, IL
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Oak Park, IL
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Oak Park, IL
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Baltimore, MD
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Boston, MA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Emerson, NJ
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Emerson, NJ
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Summit, NJ
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Summit, NJ
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Tom's River, NJ
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Tom's River, NJ
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
New York, NY
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Willoughby, OH
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Willoughby, OH
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Wyomissing, PA
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Lewisville, TX
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Lewisville, TX
Click here to add this to my saved trials
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
McAllen, TX
Evaluation of CureXcell® in Treating Chronic Venous Leg Ulcers
A Phase-3 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell® as an Adjunct to Good Ulcer Care Measures in Treating Chronic Venous Leg Ulcers
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials